Intervention Protocol

Beta-blockers for prevention of oesophageal variceal rebleeding in cirrhotic patients

  1. Wendong Chen1,*,
  2. Sarah Louise Klingenberg2,
  3. Dimitrinka Nikolova2,
  4. Christian Gluud2

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 18 OCT 2006

DOI: 10.1002/14651858.CD004545.pub2


How to Cite

Chen W, Klingenberg SL, Nikolova D, Gluud C. Beta-blockers for prevention of oesophageal variceal rebleeding in cirrhotic patients (Protocol). Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD004545. DOI: 10.1002/14651858.CD004545.pub2.

Author Information

  1. 1

    Toronto Health Economics and Technology Assessment Collaborative (THETA), University of Toronto, Departments of Health Policy Management and Evaluation, and Pharmacy, Toronto, Ontario, Canada

  2. 2

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Wendong Chen, Departments of Health Policy Management and Evaluation, and Pharmacy, Toronto Health Economics and Technology Assessment Collaborative (THETA), University of Toronto, Room 679, 6th floor, Leslie L. Dan Pharmacy Building , 144 College Street, Toronto, Ontario, M5S 3M2 , Canada. wdchen@uhnres.utoronto.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2006

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This systematic review will evaluate the beneficial and harmful effects of beta-blockers on preventing oesophageal variceal rebleeding in cirrhotic patients who survived a variceal bleeding.